Announcement

Collapse
No announcement yet.

J Infect Public Health . Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • J Infect Public Health . Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2


    J Infect Public Health


    . 2020 Dec 21;14(2):227-237.
    doi: 10.1016/j.jiph.2020.12.014. Online ahead of print.
    Identification of potential SARS-CoV-2 entry inhibitors by targeting the interface region between the spike RBD and human ACE2


    Arun Bahadur Gurung 1 , Mohammad Ajmal Ali 2 , Joongku Lee 3 , Mohammad Abul Farah 4 , Khalid Mashay Al-Anazi 4



    Affiliations

    Abstract

    Coronavirus disease 2019 (COVID-19) is a fatal infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The virus infection is initiated upon recognition and binding of the spike (S) protein receptor-binding domain (RBD) to the host cell surface receptor, angiotensin-converting enzyme 2 (ACE2). Blocking the interaction between S protein and ACE2 receptor is a novel approach to prevent the viral entry into the host cell. The present study is aimed at the identification of small molecules which can disrupt the interaction between SARS-CoV-2 S protein and human ACE2 receptor by binding to the interface region. A chemical library consisting of 1,36,191 molecules were screened for drug-like compounds based on Lipinski's rule of five, Verber's rule and in silico toxicity parameters. The filtered drug-like molecules were next subjected to molecular docking in the interface region of RBD. The best three hits viz; ZINC64023823, ZINC33039472 and ZINC00991597 were further taken for molecular dynamics (MD) simulation studies and binding free energy evaluations using Molecular mechanics-Poisson-Boltzmann surface area (MM-PBSA) and Molecular mechanics-Generalized Born surface area (MM-GBSA). The protein-ligand complexes showed stable trajectories throughout the simulation time. ZINC33039472 exhibited binding free energy value lower as compared to the control (emodin) with a higher contribution by gas-phase energy and van der Waals energy to the total binding free energy. Thus, ZINC33039472 is identified to be a promising interfacial binding molecule which can inhibit the interaction between the viral S protein and human ACE2 receptor which would consequently help in the management of the disease.

    Keywords: ACE2; Angiotensin-converting enzyme 2; COVID-19; Molecular docking; Molecular dynamics simulation; Protein–protein interface; RBD; Receptor-binding domain; SARS-CoV-2; Spike protein.

Working...
X